Cargando…

Global gene expression profile progression in Gaucher disease mouse models

BACKGROUND: Gaucher disease is caused by defective glucocerebrosidase activity and the consequent accumulation of glucosylceramide. The pathogenic pathways resulting from lipid laden macrophages (Gaucher cells) in visceral organs and their abnormal functions are obscure. RESULTS: To elucidate this p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, You-Hai, Jia, Li, Quinn, Brian, Zamzow, Matthew, Stringer, Keith, Aronow, Bruce, Sun, Ying, Zhang, Wujuan, Setchell, Kenneth DR, Grabowski, Gregory A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032697/
https://www.ncbi.nlm.nih.gov/pubmed/21223590
http://dx.doi.org/10.1186/1471-2164-12-20
_version_ 1782197485313196032
author Xu, You-Hai
Jia, Li
Quinn, Brian
Zamzow, Matthew
Stringer, Keith
Aronow, Bruce
Sun, Ying
Zhang, Wujuan
Setchell, Kenneth DR
Grabowski, Gregory A
author_facet Xu, You-Hai
Jia, Li
Quinn, Brian
Zamzow, Matthew
Stringer, Keith
Aronow, Bruce
Sun, Ying
Zhang, Wujuan
Setchell, Kenneth DR
Grabowski, Gregory A
author_sort Xu, You-Hai
collection PubMed
description BACKGROUND: Gaucher disease is caused by defective glucocerebrosidase activity and the consequent accumulation of glucosylceramide. The pathogenic pathways resulting from lipid laden macrophages (Gaucher cells) in visceral organs and their abnormal functions are obscure. RESULTS: To elucidate this pathogenic pathway, developmental global gene expression analyses were conducted in distinct Gba1 point-mutated mice (V394L/V394L and D409 V/null). About 0.9 to 3% of genes had altered expression patterns (≥ ± 1.8 fold change), representing several categories, but particularly macrophage activation and immune response genes. Time course analyses (12 to 28 wk) of INFγ-regulated pro-inflammatory (13) and IL-4-regulated anti-inflammatory (11) cytokine/mediator networks showed tissue differential profiles in the lung and liver of the Gba1 mutant mice, implying that the lipid-storage macrophages were not functionally inert. The time course alterations of the INFγ and IL-4 pathways were similar, but varied in degree in these tissues and with the Gba1 mutation. CONCLUSIONS: Biochemical and pathological analyses demonstrated direct relationships between the degree of tissue glucosylceramides and the gene expression profile alterations. These analyses implicate IFNγ-regulated pro-inflammatory and IL-4-regulated anti-inflammatory networks in differential disease progression with implications for understanding the Gaucher disease course and pathophysiology.
format Text
id pubmed-3032697
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30326972011-02-04 Global gene expression profile progression in Gaucher disease mouse models Xu, You-Hai Jia, Li Quinn, Brian Zamzow, Matthew Stringer, Keith Aronow, Bruce Sun, Ying Zhang, Wujuan Setchell, Kenneth DR Grabowski, Gregory A BMC Genomics Research Article BACKGROUND: Gaucher disease is caused by defective glucocerebrosidase activity and the consequent accumulation of glucosylceramide. The pathogenic pathways resulting from lipid laden macrophages (Gaucher cells) in visceral organs and their abnormal functions are obscure. RESULTS: To elucidate this pathogenic pathway, developmental global gene expression analyses were conducted in distinct Gba1 point-mutated mice (V394L/V394L and D409 V/null). About 0.9 to 3% of genes had altered expression patterns (≥ ± 1.8 fold change), representing several categories, but particularly macrophage activation and immune response genes. Time course analyses (12 to 28 wk) of INFγ-regulated pro-inflammatory (13) and IL-4-regulated anti-inflammatory (11) cytokine/mediator networks showed tissue differential profiles in the lung and liver of the Gba1 mutant mice, implying that the lipid-storage macrophages were not functionally inert. The time course alterations of the INFγ and IL-4 pathways were similar, but varied in degree in these tissues and with the Gba1 mutation. CONCLUSIONS: Biochemical and pathological analyses demonstrated direct relationships between the degree of tissue glucosylceramides and the gene expression profile alterations. These analyses implicate IFNγ-regulated pro-inflammatory and IL-4-regulated anti-inflammatory networks in differential disease progression with implications for understanding the Gaucher disease course and pathophysiology. BioMed Central 2011-01-11 /pmc/articles/PMC3032697/ /pubmed/21223590 http://dx.doi.org/10.1186/1471-2164-12-20 Text en Copyright ©2011 Xu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xu, You-Hai
Jia, Li
Quinn, Brian
Zamzow, Matthew
Stringer, Keith
Aronow, Bruce
Sun, Ying
Zhang, Wujuan
Setchell, Kenneth DR
Grabowski, Gregory A
Global gene expression profile progression in Gaucher disease mouse models
title Global gene expression profile progression in Gaucher disease mouse models
title_full Global gene expression profile progression in Gaucher disease mouse models
title_fullStr Global gene expression profile progression in Gaucher disease mouse models
title_full_unstemmed Global gene expression profile progression in Gaucher disease mouse models
title_short Global gene expression profile progression in Gaucher disease mouse models
title_sort global gene expression profile progression in gaucher disease mouse models
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032697/
https://www.ncbi.nlm.nih.gov/pubmed/21223590
http://dx.doi.org/10.1186/1471-2164-12-20
work_keys_str_mv AT xuyouhai globalgeneexpressionprofileprogressioningaucherdiseasemousemodels
AT jiali globalgeneexpressionprofileprogressioningaucherdiseasemousemodels
AT quinnbrian globalgeneexpressionprofileprogressioningaucherdiseasemousemodels
AT zamzowmatthew globalgeneexpressionprofileprogressioningaucherdiseasemousemodels
AT stringerkeith globalgeneexpressionprofileprogressioningaucherdiseasemousemodels
AT aronowbruce globalgeneexpressionprofileprogressioningaucherdiseasemousemodels
AT sunying globalgeneexpressionprofileprogressioningaucherdiseasemousemodels
AT zhangwujuan globalgeneexpressionprofileprogressioningaucherdiseasemousemodels
AT setchellkennethdr globalgeneexpressionprofileprogressioningaucherdiseasemousemodels
AT grabowskigregorya globalgeneexpressionprofileprogressioningaucherdiseasemousemodels